154 related articles for article (PubMed ID: 10383148)
1. NG2 proteoglycan-binding peptides target tumor neovasculature.
Burg MA; Pasqualini R; Arap W; Ruoslahti E; Stallcup WB
Cancer Res; 1999 Jun; 59(12):2869-74. PubMed ID: 10383148
[TBL] [Abstract][Full Text] [Related]
2. Expression of the NG2 proteoglycan enhances the growth and metastatic properties of melanoma cells.
Burg MA; Grako KA; Stallcup WB
J Cell Physiol; 1998 Nov; 177(2):299-312. PubMed ID: 9766527
[TBL] [Abstract][Full Text] [Related]
3. NG2 proteoglycan as a pericyte target for anticancer therapy by tumor vessel infarction with retargeted tissue factor.
Brand C; Schliemann C; Ring J; Kessler T; Bäumer S; Angenendt L; Mantke V; Ross R; Hintelmann H; Spieker T; Wardelmann E; Mesters RM; Berdel WE; Schwöppe C
Oncotarget; 2016 Feb; 7(6):6774-89. PubMed ID: 26735180
[TBL] [Abstract][Full Text] [Related]
4. The NG2 chondroitin sulfate proteoglycan: a multifunctional proteoglycan associated with immature cells.
Levine JM; Nishiyama A
Perspect Dev Neurobiol; 1996; 3(4):245-59. PubMed ID: 9117258
[TBL] [Abstract][Full Text] [Related]
5. Targeting bladder tumor cells in vivo and in the urine with a peptide identified by phage display.
Lee SM; Lee EJ; Hong HY; Kwon MK; Kwon TH; Choi JY; Park RW; Kwon TG; Yoo ES; Yoon GS; Kim IS; Ruoslahti E; Lee BH
Mol Cancer Res; 2007 Jan; 5(1):11-9. PubMed ID: 17259343
[TBL] [Abstract][Full Text] [Related]
6. Targeting of tumor blood vessels: a phage-displayed tumor-homing peptide specifically binds to matrix metalloproteinase-2-processed collagen IV and blocks angiogenesis in vivo.
Mueller J; Gaertner FC; Blechert B; Janssen KP; Essler M
Mol Cancer Res; 2009 Jul; 7(7):1078-85. PubMed ID: 19584266
[TBL] [Abstract][Full Text] [Related]
7. A central segment of the NG2 proteoglycan is critical for the ability of glioma cells to bind and migrate toward type VI collagen.
Burg MA; Nishiyama A; Stallcup WB
Exp Cell Res; 1997 Aug; 235(1):254-64. PubMed ID: 9281375
[TBL] [Abstract][Full Text] [Related]
8. NG2 proteoglycan mediates beta1 integrin-independent cell adhesion and spreading on collagen VI.
Tillet E; Gential B; Garrone R; Stallcup WB
J Cell Biochem; 2002; 86(4):726-36. PubMed ID: 12210739
[TBL] [Abstract][Full Text] [Related]
9. NG2 expression regulates vascular morphology and function in human brain tumours.
Brekke C; Lundervold A; Enger PØ; Brekken C; Stålsett E; Pedersen TB; Haraldseth O; Krüger PG; Bjerkvig R; Chekenya M
Neuroimage; 2006 Feb; 29(3):965-76. PubMed ID: 16253523
[TBL] [Abstract][Full Text] [Related]
10. A new phage-display tumor-homing peptide fused to antiangiogenic peptide generates a novel bioactive molecule with antimelanoma activity.
Matsuo AL; Juliano MA; Figueiredo CR; Batista WL; Tanaka AS; Travassos LR
Mol Cancer Res; 2011 Nov; 9(11):1471-8. PubMed ID: 21900362
[TBL] [Abstract][Full Text] [Related]
11. Functional and morphological effects of NG2 proteoglycan deletion on hippocampal neurogenesis.
Thallmair M; Ray J; Stallcup WB; Gage FH
Exp Neurol; 2006 Nov; 202(1):167-78. PubMed ID: 16814771
[TBL] [Abstract][Full Text] [Related]
12. Molecular basis of interaction between NG2 proteoglycan and galectin-3.
Wen Y; Makagiansar IT; Fukushi J; Liu FT; Fukuda MN; Stallcup WB
J Cell Biochem; 2006 May; 98(1):115-27. PubMed ID: 16365873
[TBL] [Abstract][Full Text] [Related]
13. NG2/HMP proteoglycan as a cancer therapeutic target.
Chekenya M; Immervoll H
Methods Mol Biol; 2007; 361():93-117. PubMed ID: 17172708
[TBL] [Abstract][Full Text] [Related]
14. Lack of expression of the chondroitin sulphate proteoglycan neuron-glial antigen 2 on candidate stem cell populations in paediatric acute myeloid leukaemia/abn(11q23) and acute lymphoblastic leukaemia/t(4;11).
Neudenberger J; Hotfilder M; Rosemann A; Langebrake C; Reinhardt D; Pieters R; Schrauder A; Schrappe M; Röttgers S; Harbott J; Vormoor J
Br J Haematol; 2006 May; 133(3):337-44. PubMed ID: 16643437
[TBL] [Abstract][Full Text] [Related]
15. Mixed primary culture and clonal analysis provide evidence that NG2 proteoglycan-expressing cells after spinal cord injury are glial progenitors.
Yoo S; Wrathall JR
Dev Neurobiol; 2007 Jun; 67(7):860-74. PubMed ID: 17506499
[TBL] [Abstract][Full Text] [Related]
16. Differential binding of drugs containing the NGR motif to CD13 isoforms in tumor vessels, epithelia, and myeloid cells.
Curnis F; Arrigoni G; Sacchi A; Fischetti L; Arap W; Pasqualini R; Corti A
Cancer Res; 2002 Feb; 62(3):867-74. PubMed ID: 11830545
[TBL] [Abstract][Full Text] [Related]
17. NG2 proteoglycan increases mesangial cell proliferation and extracellular matrix production.
Xiong J; Wang Y; Zhu Z; Liu J; Wang Y; Zhang C; Hammes HP; Lang F; Feng Y
Biochem Biophys Res Commun; 2007 Oct; 361(4):960-7. PubMed ID: 17686464
[TBL] [Abstract][Full Text] [Related]
18. NG2 proteoglycan-expressing microglia as multipotent neural progenitors in normal and pathologic brains.
Yokoyama A; Sakamoto A; Kameda K; Imai Y; Tanaka J
Glia; 2006 May; 53(7):754-68. PubMed ID: 16534776
[TBL] [Abstract][Full Text] [Related]
19. Selection of recombinant phages binding to pathological endothelial and tumor cells of rat glioblastoma by in-vivo display.
Schluesener HJ; Xianglin T
J Neurol Sci; 2004 Sep; 224(1-2):77-82. PubMed ID: 15450774
[TBL] [Abstract][Full Text] [Related]
20. In vitro targeting of NG2 antigen by 213Bi-9.2.27 alpha-immunoconjugate induces cytotoxicity in human uveal melanoma cells.
Li Y; Wang J; Rizvi SM; Jager MJ; Conway RM; Billson FA; Allen BJ; Madigan MC
Invest Ophthalmol Vis Sci; 2005 Dec; 46(12):4365-71. PubMed ID: 16303921
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
